1Shimizu M, Saitoh Y, Itoh H. Immunohistochemieal staining of haras oncogene product in normal, benign, and malignant human pancreatic tissues [ J ]. Hum Pathol, 1990,21 (6) :607-612.
2Tammela T, Enholm B, Alitalo K, et al. The biology of vascular endothelial growth fartorc [J]. Cardiovasc Res, 2005,15(3) :550-563.
3Elagoz S, Egilmez R, Koyuneu A, et al. The intratumoral mierovessel density and expression of bFGF and nm23-H1 in eoloreetal cancer [J]. Pathol Oneol Hes, 2006,12 ( 1 ) :21-27.
4Maekawa S, Lwasaki A, Shirakusa T, et al. Correlation between lymph node melaslasis and the expression of VEGF-C ,VEGF-D and VEGFR-3 in T1 lung adenocareinoma [ J ]. Anticancer Res, 2007, 27(6) :3735.
5Yonemura Y, Fushida S, Bando E, et al. Lymphangiogenesis and the vascular endothelial growth factor receptor (VEGFR)-3 in gastric cancer [J]. Eur J Cancer, 2001,37(7) :918-923.
6Shida A, Fujioka S, Kobayashi K, et al. Expression of vascular endothelial growth factor (VEGF)-C and -D in gastric carcinoma [ J]. Int J Clin Oncol, 2006,11 ( 1 ) :3843.
